Virus-free plasma protein compositions treated with porous membrane and process for producing the same
Contaminant viruses can be efficiently removed almost without losing the activity of protein by subjecting a plasma protein composition having a high risk of viral contamination to a treatment with a porous membrane having a pore size greater than a single-particle size of the virus, particularly by subjecting a plasma protein composition to a fractionation treatment by precipitation, before the porous membrane treatment. Particularly, a fibrinogen composition substantially free of non-enveloped viruses, Parvovirus among others, can be provided. By the application of the present invention, a safe plasma protein preparation free of viruses can be conveniently provided.
1. A production method for producing a plasma protein composition containing fibrinogen free of detectable virus, which comprises:
subjecting the plasma protein composition containing fibrinogen to a fractionation treatment by precipitation to obtain a precipitate;
extracting the precipitate with water; and
subjecting the extracted precipitate to a treatment with a porous membrane having a pore size greater than a single-particle size of the virus, wherein the average pore size is 35±2 nm and wherein the virus is parvovirus or encephalomyocarditis virus to produce the plasma protein composition free of detectable virus.
2. The production method according to claim 1 , wherein porous membrane is a porous hollow fiber membrane.
3. A method for removing detectable virus in plasma protein composition containing fibrinogen, which comprises:
subjecting the plasma protein composition containing fibrinogen to a fractionation treatment by precipitation to obtain a precipitate;
extracting the precipitate with water; and
subjecting the extracted precipitate to a treatment with a porous membrane having a pore size greater than a single-particle size of the virus, wherein the average pore size is 35±2 nm and wherein the virus is parvovirus or encephalomyocarditis virus to produce the plasma protein composition free of detectable virus.
4. The method according to claim 3 , wherein the porous membrane is a porous hollow fiber membrane.
5. A method for producing a plasma protein composition comprising fibrinogen free of detectable parvovirus or encephalomyocarditis virus, which comprises:
subjecting the plasma protein composition comprising fibrinogen to a fractionation treatment by precipitation to obtain a precipitate;
subjecting the precipitate to a treatment with a porous membrane having a pore size greater than a single-particle size of the virus, wherein the average pore size is 35±2 nm and the treatment with the porous membrane is conducted a plural number of times to produce the plasma protein composition free of detectable parvovirus or encephalomyocarditis virus.
6. The method according to claim 5 , wherein the treatment with the porous membrane is conducted a plural number of times using a porous membrane having a different average pore size.
7. A method for removing detectable parvovirus or encephalomyocarditis virus in a plasma protein composition comprising fibrinogen, which comprises:
subjecting the plasma protein composition comprising fibrinogen to a fractionation treatment by precipitation to obtain a precipitate; and
subjecting the precipitate to a treatment with a porous membrane having pore size greater than a single-particle size of the virus, wherein the average pore size is 35±2 nm, and the treatment with the porous membrane is conducted a plural number of times to produce the plasma protein composition free of detectable parvovirus or encephalomyocarditis virus.
8. The method according to claim 7 , wherein the treatment with the porous membrane is conducted a plural number of times using a porous membrane having a different average pore size.